IHI vs. BMED

Last updated Jul 18, 2026

IHI (iShares U.S. Medical Devices ETF) and BMED (Future Health ETF) are both Health & Biotech Equities funds. IHI is passively managed, while BMED is actively managed. Over the past 5 years, IHI returned -3.26%/yr vs 0.66%/yr for BMED. A 0.77 correlation means they provide meaningful diversification when combined. IHI charges 0.38%/yr vs 0.85%/yr for BMED.

Performance

IHI vs. BMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares U.S. Medical Devices ETF (IHI) and Future Health ETF (BMED). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, IHI achieves a -18.54% return, which is significantly lower than BMED's 1.37% return.

IHI

• 1D: -3.24%
• 1M: 4.36%
• 6M: -18.12%
• YTD: -18.54%
• 1Y: -15.41%
• 3Y*: -3.16%
• 5Y*: -3.26%
• 10Y*: 8.43%

BMED

• 1D: -0.49%
• 1M: 7.89%
• 6M: -1.39%
• YTD: 1.37%
• 1Y: 23.25%
• 3Y*: 7.31%
• 5Y*: 0.66%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

IHI vs. BMED - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
IHI iShares U.S. Medical Devices ETF	-18.54%	6.88%	8.62%	3.24%	-19.80%	21.03%	9.38%
BMED Future Health ETF	1.37%	21.79%	1.55%	5.70%	-19.69%	-3.96%	17.62%

Correlation

The correlation between IHI and BMED is 0.63, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.63
Correlation (3Y) Calculated over the trailing 3-year period	0.69
Correlation (5Y) Calculated over the trailing 5-year period	0.78
Correlation (All Time) Calculated using the full available price history since Oct 1, 2020	0.77

The correlation between IHI and BMED shifts across timeframes, from 0.63 (1 year) to 0.78 (5 years), reflecting how their relationship changes across market environments.

IHI vs. BMED - Sectors Allocation Comparison

Sectors	IHI	BMED
Healthcare	100.0%	100.0%
Technology	0.3%	-
Industrials	0.2%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	1.5%
Energy	-	-
Financial Services	-	-
Real Estate	-	-
Utilities	-	-

Return for Risk

IHI vs. BMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IHI

IHI Risk / Return Rank: 3
IHI Sharpe Ratio Rank: 3
IHI Sortino Ratio Rank: 3
IHI Omega Ratio Rank: 3
IHI Calmar Ratio Rank: 4
IHI Martin Ratio Rank: 3

BMED

BMED Risk / Return Rank: 47
BMED Sharpe Ratio Rank: 56
BMED Sortino Ratio Rank: 59
BMED Omega Ratio Rank: 51
BMED Calmar Ratio Rank: 39
BMED Martin Ratio Rank: 32

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IHI vs. BMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Medical Devices ETF (IHI) and Future Health ETF (BMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	IHI	BMED	Difference
Sharpe ratio: Return per unit of total volatility	-0.79	1.48	-2.27
Sortino ratio: Return per unit of downside risk	-1.04	2.19	-3.23
Omega ratio: Gain probability vs. loss probability	0.88	1.25	-0.37
Calmar ratio: Return relative to maximum drawdown	-0.59	1.57	-2.16
Martin ratio: Return relative to average drawdown	-1.22	3.64	-4.86

IHI vs. BMED - Sharpe Ratio Comparison

The current IHI Sharpe Ratio is -0.79, which is lower than the BMED Sharpe Ratio of 1.48. The chart below compares the historical Sharpe Ratios of IHI and BMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

IHI vs. BMED - Drawdown Comparison

The maximum IHI drawdown since its inception was -49.65%, which is greater than BMED's maximum drawdown of -36.44%. Use the drawdown chart below to compare losses from any high point for IHI and BMED.

Drawdown Indicators

	IHI	BMED	Difference
Max Drawdown Largest peak-to-trough decline	-49.65%	-36.44%	-13.21%
Max Drawdown (1Y) Largest decline over 1 year	-26.11%	-14.85%	-11.26%
Max Drawdown (3Y) Largest decline over 3 years	-26.64%	-20.12%	-6.52%
Max Drawdown (5Y) Largest decline over 5 years	-33.12%	-33.90%	+0.78%
Max Drawdown (10Y) Largest decline over 10 years	-33.25%	—	—
Current Drawdown Current decline from peak	-23.08%	-5.03%	-18.05%
Average Drawdown Average peak-to-trough decline	-8.41%	-18.84%	+10.43%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.63%	6.41%	+6.22%

Volatility

IHI vs. BMED - Volatility Comparison

iShares U.S. Medical Devices ETF (IHI) has a higher volatility of 10.17% compared to Future Health ETF (BMED) at 5.23%. This indicates that IHI's price experiences larger fluctuations and is considered to be riskier than BMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IHI	BMED	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.17%	5.23%	+4.94%
Volatility (6M) Calculated over the trailing 6-month period	16.15%	12.01%	+4.14%
Volatility (1Y) Calculated over the trailing 1-year period	19.55%	15.82%	+3.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.48%	17.56%	+1.92%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.98%	17.77%	+2.21%

IHI vs. BMED - Expense Ratio Comparison

IHI has a 0.38% expense ratio, which is lower than BMED's 0.85% expense ratio.

Dividends

IHI vs. BMED - Dividend Comparison

IHI's dividend yield for the trailing twelve months is around 0.48%, more than BMED's 0.26% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BMED Future Health ETF	0.26%	0.00%	0.00%	0.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
IHI iShares U.S. Medical Devices ETF	0.48%	0.34%	0.46%	0.53%	0.45%	0.25%	0.25%	0.33%	0.26%	0.37%	0.55%	1.28%

Frequently Asked Questions

Can I hold both IHI and BMED in my portfolio?

IHI and BMED have a correlation of 0.63, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, IHI or BMED?

IHI has higher volatility (10.17%) compared to BMED (5.23%). In terms of maximum drawdown, IHI dropped -49.65% vs BMED's -36.44%.

Which ETF is better, IHI or BMED?

On 5-year performance, BMED leads with 0.66% vs -3.26% for IHI. On fees, IHI is cheaper at 0.38% per year. On volatility, BMED has been the lower-risk option at 5.23%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, IHI or BMED?

Over the 5-year period, BMED has performed better with a 0.66% return vs -3.26%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, IHI or BMED?

IHI is cheaper with a 0.38% expense ratio, compared with 0.85% for BMED.

Which ETF pays a higher dividend yield, IHI or BMED?

IHI has the higher dividend yield at 0.48%, compared with 0.26% for BMED.

What is the main difference between IHI and BMED?

They also come from different issuers: iShares and BlackRock. Their fees differ too: 0.38% for IHI and 0.85% for BMED.

Which has better risk-adjusted returns?

BMED currently has the higher Sharpe Ratio (1.48 vs -0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.